Skip to main content
. 2022 Feb;11(2):201–212. doi: 10.21037/tlcr-22-49

Table 1. Baseline characteristics.

Characteristic Total (n=34)
Age, years
   Median [range] 60 [37–72]
Sex, n (%)
   Male 23 (67.6)
   Female 11 (32.4)
ECOG PS, n (%)
   0–1 25 (73.5)
   2 9 (26.5)
Tumor histology, n (%)
   Adenocarcinoma 22 (64.7)
   Squamous 8 (23.5)
   Other 4 (11.8)
Smoking status, n (%)
   Current or former smoker 17 (50.0)
   Never smoker 17 (50.0)
No. of prior systemic therapies, n (%)
   1 8 (23.5)
   2 15 (44.1)
   >2 11 (32.4)
No. of organs with metastasis, n (%)
   ≤2 24 (70.6)
   >2 10 (29.4)
Brain metastasis, n (%)
   Yes 8 (23.5)
   No 26 (76.5)
Liver metastasis, n (%)
   Yes 9 (26.5)
   No 25 (73.5)
Prior anti-angiogenesis therapy, n (%)
   Yes 16 (47.1)
   No 18 (52.9)

ECOG PS, Eastern Cooperative Oncology Group performance status.